Purchase Order W81XWH21P0202
Award Date 9/20/21
Potential Completion Date 9/29/26
Potential Value $1.4M
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Fairfield, NJ 07004, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This firm-fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Vela Diagnostics USA Inc. to provide maintenance services for the Sentosa SQ HIV genotyping systems. The contract has a potential value of $100,000.00 and a period of performance ending on September 29, 2027. Vela Diagnostics USA Inc. is a global provider of integrated molecular diagnostic solutions that has previously supported federal agencies such as the Department of Veterans...
- The Centers for Disease Control and Prevention (CDC) awarded a firm fixed price purchase order to Vela Diagnostics USA Inc. for $31,206.40 to procure Sentosa SQ HIV genotyping reagent kits and consumables. This sole source award is for the FDA-approved Next Generation Sequencing (NGS) HIV-1 drug resistance assay, which Vela Diagnostics is the sole manufacturer of. The place of performance is Fairfield, New Jersey. This award is not associated with a larger contract vehicle and does not have a...
- The Department of Veterans Affairs Veterans Health Administration awarded a firm fixed-price purchase order to Vela Diagnostics USA Inc., a for-profit organization, to provide viral next-generation sequencing (NGS) testing for genotyping and resistance of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) at a cost of $148,104.85. The contract, which was not set aside, has a completion date of September 30, 2022. Vela Diagnostics USA Inc. has previously provided federal agencies,...
- This federal contract was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 16 to Vela Diagnostics USA Inc., a for-profit organization, for the VELA DIAGNOSTICS VIROKEY SENTOSA requirement. The award, made on January 13, 2021, is a firm-fixed-price purchase order with a potential value of $436,564.36 and a completion date of December 31, 2021. The contract does not have a set-aside designation. Through this award, Vela Diagnostics...
- This is a firm fixed price purchase order awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 16 to Vela Diagnostics USA Inc., a for-profit organization, for the provision of laboratory testing equipment. The contract has a total small business set-aside designation and a potential value of $149,000.00. It supports the national interest action code for the Coronavirus COVID-19 response. Through past prime federal contract awards,...
- The Department of Veterans Affairs Veterans Health Administration awarded a firm fixed price purchase order to Vela Diagnostics USA Inc. to provide COVID-19 VELA TESTING REAGENTS AND CONSUMABLES. The contract, with a potential value of $184,029.47, has a completion date of June 25, 2021 and was awarded on June 11, 2020. This award, which did not have a set-aside, was made in support of the Coronavirus COVID-19 national interest action. Vela Diagnostics USA Inc. is a for-profit organization...
- This federal contract award, with an ID of 75D30122P13718, was made by the Centers for Disease Control and Prevention (CDC) to Vela Diagnostics USA Inc. for the provision of SENTOSA SQ HIV-1 GENOTYPING ASSAY REAGENTS. The contract has a firm fixed price of $99,339.90 and a completion date of May 31, 2023. Vela Diagnostics USA Inc. is a global provider of integrated molecular diagnostic solutions for infectious diseases and cancer, and this award supports the CDC's critical public health...
- The U.S. Navy Bureau of Medicine and Surgery awarded a delivery order valued at $3.06 million to Center For Disease Detection, LLC for initial HIV antibody and antigen (HIV AB AG) screening services. The contract, awarded on May 1, 2023, with an ultimate completion date of September 21, 2023, operates on a firm fixed-price basis with no set-aside designation. Center For Disease Detection, a subsidiary of Laboratory Corporation of America Holdings based in San Antonio, Texas, will perform the...
- This federal contract award is for HIV force testing services for the U.S. Army Medical Command (MEDCOM). The $6,303,692.40 firm fixed price delivery order was awarded to Center for Disease Detection, LLC, a subsidiary of Laboratory Corporation of America Holdings that specializes in infectious disease testing for government agencies. The work will be performed in San Antonio, Texas and supports the military's efforts to monitor and address HIV prevalence among service members. This award is...
- The Defense Health Agency awarded a $115,666 firm fixed-price purchase order to Illumina, Inc. for Viral Surveillance Panel Kits to support the Department of Clinical Investigation at Tripler Army Medical Center in Hawaii. The award, issued July 21, 2025, requires delivery by September 30, 2025, and includes Illumina Viral Surveillance Panel v2 Kits (Sets A, B, C, and D), MiSeq Reagent Kit v3, NextSeq 1000/2000 P1 XLEAP-SBS Reagent Kits, and Illumina RNA Fast Hyb Enrichment products for use with...